Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VHB Life Sciences is an India-based pharmaceutical company focused on the manufacture, marketing, and export of branded generic formulations. The company operates through the broader VHB Group and appears to market a wide therapeutic portfolio spanning hormones, gonadotropins, anti-infectives, anesthetics, corticosteroids, hematinics, and other finished-dose medicines. Publicly available sources describe VHB as a vertically integrated pharmaceutical organization with a significant export footprint across regulated, semi-regulated, and emerging markets. Rather than an R&D-stage biotech with a disclosed novel clinical pipeline, VHB is best characterized as a commercial generics and specialty formulations business with manufacturing and international distribution capabilities. The company is headquartered in Mumbai, India and is active in global pharmaceutical supply and product registrations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VHB Lifesciences.